Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Cash from Financing Activities: 2019-2025

Historic Cash from Financing Activities for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Sep 2025 value amounting to -$3.0 million.

  • Harmony Biosciences Holdings' Cash from Financing Activities fell 154.98% to -$3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.8 million, marking a year-over-year increase of 85.80%. This contributed to the annual value of -$11.0 million for FY2024, which is 89.58% up from last year.
  • Latest data reveals that Harmony Biosciences Holdings reported Cash from Financing Activities of -$3.0 million as of Q3 2025, which was down 11.54% from -$2.7 million recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' Cash from Financing Activities registered a high of $7.1 million during Q4 2021, and its lowest value of -$55.1 million during Q3 2023.
  • Over the past 3 years, Harmony Biosciences Holdings' median Cash from Financing Activities value was -$2.7 million (recorded in 2024), while the average stood at -$11.1 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first spiked by 11,425.00% in 2022, then slumped by 2,787.76% in 2023.
  • Over the past 5 years, Harmony Biosciences Holdings' Cash from Financing Activities (Quarterly) stood at $7.1 million in 2021, then plummeted by 62.42% to $2.7 million in 2022, then slumped by 2,113.66% to -$53.5 million in 2023, then skyrocketed by 94.88% to -$2.7 million in 2024, then plummeted by 154.98% to -$3.0 million in 2025.
  • Its Cash from Financing Activities was -$3.0 million in Q3 2025, compared to -$2.7 million in Q2 2025 and -$352,000 in Q1 2025.